Moleculin Biotech
MBRX
MBRX
22 hedge funds and large institutions have $4.26M invested in Moleculin Biotech in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$137K | |
| 2 | +$65.9K | |
| 3 | +$29.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$19K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$13K |
Top Sellers
| 1 | -$106K | |
| 2 | -$45.5K | |
| 3 | -$42K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$31K |
| 5 |
HF
HRT Financial
New York
|
-$22K |